Opinion
The latest opinion pieces by industry thought leaders
If you are interested in having your voice heard on PharmaVoice's Opinion page, please read our editorial guidelines and fill out the submission form here.
-
Stock via Getty Images
What would you fix with a ‘magic wand’? Pharma leaders chime in about clinical trials
How life science execs would transform clinical trials with a little hocus pocus.
PharmaVoice staff • March 24, 2023 -
Stock via Getty Images
How biotechs can weather the market storm
Execs at JPM sound off on moves companies can make to survive the challenging market conditions.
Meagan Parrish • Jan. 13, 2023 -
Stock via Getty Images
The 2023 PharmaVoice Crystal Ball: Peering into the future of life sciences
A preview of the top trends on the minds of industry and market leaders for the new year.
Taren Grom • Jan. 3, 2023 -
Stock via Getty Images
WoW: What a year
A look back at some of the most inspirational quotes from the Women of the Week podcasts in 2022.
Taren Grom • Dec. 20, 2022 -
Stock via Getty Images
Healthcare tech’s biggest busts
The metaverse, blockchain, DCTs and more — here are some of the most recent fails in healthcare tech.
Taren Grom • Dec. 2, 2022 -
Stock via Getty Images
Hybrid work is here to stay — here’s how leaders should adjust
Executives across the life sciences share their tips for navigating the new norm of remote work.
Taren Grom • Nov. 18, 2022 -
iStock via Getty Images
Why the IRA will drive up the country’s drug bill — not lower it
On the surface, the Inflation Reduction Act is designed to lower drug prices, but its impact on innovation incentives could produce a landscape of new medicines that are costlier for patients.
John LaMattina • Nov. 14, 2022 -
Stock via Getty Images
Pharma execs on creating a better workplace culture
Top women execs speak to the leadership skills they are embracing as the industry adjusts to a new normal.
Taren Grom • Oct. 28, 2022 -
Stock via Getty Images
What’s keeping pharma leaders up at night
C-suite execs in the life sciences share their late-night thoughts including innovation, patient access and market factors.
Taren Grom • Oct. 21, 2022 -
Stock via Getty Images
What’s your leadership brand?
Pharma industry leaders share their brand personas.
Taren Grom • Oct. 14, 2022 -
Stock via Getty Images
Are you a bad boss?
Pharma execs share their tips for being a better leader.
Taren Grom • Oct. 7, 2022 -
Sophia Sharp-Donaldson, executive director, Global Strategic Sourcing and Procurement, Kite Pharma and one of this year's HBA Luminary honorees.
Why 'soft' skills matter in the new era of leadership
Standout leaders honored by the Healthcare Businesswomen's Association discuss the rising value of the interpersonal approach.
Taren Grom • May 12, 2022 -
Stock via Getty Images
Industry executives on the milestone moments shaping pharma's future
Scientific, technological, and communication changes that are making a permanent impact on the industry.
Taren Grom • Feb. 9, 2022 -
Retrieved from Google image.
Industry executives predict the next 'blue oceans' in pharma
Where life science leaders see breakthroughs happening in the industry.
Taren Grom • Feb. 4, 2022 -
Pekic via Getty Images
Talent acquisition stays top of mind for pharma execs
From creating flexible work environments to looking outside the industry for new talent, pharma execs are shifting strategies to keep their teams afloat.
Taren Grom • Feb. 1, 2022 -
Ricardo Ceppi via Getty Images
Biopharma's R&D leaders on how technology can accelerate drug development
How emerging digital tools are providing enhanced clinical insights and improved trial results.
Taren Grom • Jan. 27, 2022 -
Retrieved from Google image.
Leaders predict improving patient engagement will lead to growth opportunities
Why patient engagement is key to successful business growth.
Taren Grom • Jan. 24, 2022 -
Retrieved from Google image.
Pharma execs reveal the industry's most pressing issues
Several market factors — including COVID — are driving changes and trends in the industry.
Taren Grom • Jan. 14, 2022 -
PharmaVoice Team/PharmaVoice
Speak Out: The Value of Using Neutral Analysis in Life Sciences Disputes
Imagine that you have multiple published and peer-reviewed clinical trials and time is of the essence to get your vaccine to market. Unfortunately, you are involved in a lawsuit for patent infringement with a competitor. Will you go to trial? What are your odds of prevailing? HAVE THE RIGHT ST...
Hon. Gregory M. Sleet (Ret.) • Nov. 15, 2021 -
PharmaVoice Team/PharmaVoice
Executive Perspective: Data For Better Health Outcomes: A Conversation with Clark Wooten and Anthony Passarelli
The COVID-19 pandemic has continued to disrupt the healthcare market across all sectors, and the digital health segment is no exception. But in this case, there has been a positive boost. According to Global Market Insights, the digital health market exceeded $141.8 billion in 2020 and is estimat...
Clark Wooten • Nov. 15, 2021 -
PharmaVoice Team/PharmaVoice
Executive Perspective: The Right Man for the Job A Conversation with Andy Plump, M.D., Ph.D.
Timing in life is everything, and for Andy Plump, M.D., Ph.D., taking on the role as president of R&D at Takeda in 2015 has proven to be advantageous not only for the 239-year-old company at a time when it needed a fresh approach, but also for patients around the globe. Back in 2014, Andy ...
Dr. Andy Plump • Jan. 1, 2021 -
PharmaVoice Team/PharmaVoice
Speak Out: From Crawl to Run: Maturing Digital Engagement
In the last 5 years, the pharmaceutical industry has taken clear steps towards omnichannel engagement. In the last 5 months, the walking — and sometimes crawling — has turned into a race. And not everyone is ready to run. The core drivers of success in pharmaceutical sales have not...
Antonio Pregueiro • Sept. 1, 2020
